Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

MOR103 – Antibody for the Treatment of Rheumatoid Arthritis

Drug (brand/generic)

MOR103

Company / licensee

MorphoSys

Therapy class

Immunosuppressive agent

Product description

Human HuCAL Antibody

Current indication

Rheumatoid Arthritis

Market sector

Rheumatology

Development status

Phase II
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM

Go Top